Last updated: July 28, 2025
Introduction
The patent application WO2010138738, filed under the auspices of the World Intellectual Property Organization (WIPO), pertains to a novel pharmaceutical invention with significant implications for therapeutic development. The patent’s scope, claims, and surrounding patent landscape are essential considerations for stakeholders evaluating patent rights, potential infringement risks, licensing opportunities, and research freedom.
This analysis dissects the patent’s core claims, the scope of protection granted, and the broader patent landscape, offering insights crucial for pharmaceutical innovators, patent strategists, and legal professionals.
Overview of WO2010138738
WO2010138738 relates to a specific class of compounds with pharmaceutical utility, claimed for use in treating particular diseases, often involving complex chemical structures with therapeutic indications. As an international application published on December 30, 2010, it likely claims priority from earlier filings, and covers chemical entities, formulations, and methods of use.
The patent’s central contribution appears aligned with innovative small molecules targeting specific pathways, potentially involving kinase inhibitors or similar targeted therapies—common in modern pharmacological patenting. The detailed chemistry, mechanisms, and use claims underpin its strategic value.
Scope of the Patent
1. Chemical Class and Claims
The patent’s claims primarily cover a defined chemical genus—comprising specific substitutions on a core molecular scaffold—alongside particular stereochemistry arrangements. Claims extend to:
- Pure compounds: Distinct chemical entities or classes with narrow claim scope.
- Pharmacological compositions: Formulations containing the claimed compounds.
- Methods of treatment: Use of the compounds for specific indications, such as cancer, inflammatory conditions, or viral infections.
2. Composition and Formulation Claims
The patent also encompasses pharmaceutical compositions, covering combinations with excipients, delivery modalities, and stability aspects, broadening protective scope.
3. Method of Use Claims
Use claims specify therapeutic applications, potentially covering prophylactic or curative methods, which are often critical in defending against generic challenges and asserting market exclusivity.
4. Optional Variations and Examples
Dependent claims elaborate on substituents, specific derivatives, and method steps, providing a layered protection architecture—balancing broad core claims with narrowing subclaims for particular embodiments.
Patent Claims Analysis
Arguably the most defining aspect of the patent, the claims can be divided into:
-
Compound claims: Cover core chemical structures, often with substitutions at defined positions. For example, a claim might cover compounds of a certain formula with particular groups at R1 and R2.
-
Use claims: Covering methods of administering the compounds for treating the targeted condition, which may be formulated as "use of compound X for treatment of disease Y."
-
Composition claims: Covering the pharmaceuticals comprising the claimed compound, together with carriers and delivery agents.
Claim Breadth and Validity Risks
- The breadth of compound claims determines strength; overly broad claims risk invalidation over prior art.
- Narrow claims, while more defensible, may limit market exclusivity.
- Use claims tend to be more defendable, especially if the therapeutic effect demonstrates novelty.
Inventive Step and Novelty
- The claims presumably differentiate from prior art by novel chemical substituents, unique binding motifs, or specific mechanisms of action.
- The publication cites prior art references, indicating distinct structural features or unexpected therapeutic benefits that justify inventive step.
Patent Landscape and Market Context
1. Key Patent Families and Related Applications
The strategic patent landscape encompasses:
- Family members filed in jurisdictions such as the US, EPO, and China, extending exclusivity rights globally.
- Continuation applications expanding claim scope or narrowing specifics based on prior art settlements.
2. Overlapping Patent Rights
- Competing patents may claim similar compounds, especially within the same chemical class, leading to possible patent thickets.
- Patent offices often scrutinize novelty and inventive step, particularly where known compounds are modified.
3. Freedom-to-Operate Considerations
- Due to the specialized chemical space, freedom to develop may hinge on navigating overlapping patent rights.
- Monitoring patent families with priority dates preceding or aligning with WO2010138738 informs licensing and development strategies.
4. Litigation and Patent Challenges
- Drugs within this realm are high-stakes; patent challenges, including validity suits, can impact the monopoly duration.
- Patent office oppositions or nullity actions may target broad claims or prior art disclosures.
5. Patent Expiration and Market Entry
- Given the application date (2010), granted patents potentially expire around 2030-2035, depending on jurisdictions and patent term extensions.
- Early patent filings increasingly face patentability challenges, emphasizing the importance of strategic prosecution and continual patent filings.
Implications for Stakeholders
- Pharmaceutical companies must evaluate patent scope per jurisdiction to shape R&D and commercialization strategies.
- Legal professionals should scrutinize claim validity, potential infringements, and opportunities for patent strengthening via divisional or continuation filings.
- Investors and licensing entities should analyze patent breadth, lifecycle, and overlapping rights to assess investment risks and licensing opportunities.
Key Takeaways
- WO2010138738 claims a specific chemical class, pharmaceutical compositions, and therapeutic methods, with a layered claim architecture balancing broad and narrow protections.
- The patent landscape features related filings globally, emphasizing the importance of considering jurisdiction-specific validity and patentability criteria.
- Narrow but defensible claims, especially method-of-use rights, can offer robust protection; however, broad compound claims may face validity challenges over prior art.
- Competitive landscape analysis shows potential patent thickets, necessitating comprehensive clearance and freedom-to-operate assessments.
- Ongoing patent prosecution and strategic patent family development are critical in prolonging exclusivity and maintaining market leverage.
FAQs
Q1: What is the primary innovation claimed in WO2010138738?
A1: The patent claims a novel class of chemical compounds with specific substitutions designed for therapeutic use, alongside their formulations and methods of treating targeted diseases.
Q2: How broad are the compound claims, and what risks do they entail?
A2: The claims cover a defined chemical genus with particular substituents. Overly broad claims risk invalidation over existing prior art; narrow claims are more defensible but offer limited protection.
Q3: What is the significance of use claims in this patent?
A3: Use claims protect specific therapeutic methods employing the compounds, often providing a more secure avenue for patent enforcement compared to compound claims alone.
Q4: How does the patent landscape influence development strategies around WO2010138738?
A4: Overlapping patents and patent thickets require careful freedom-to-operate analysis, licensing negotiations, and strategic patenting to safeguard market access.
Q5: When might this patent or its family members expire?
A5: Given the filing date of 2010, the patent’s expiration is likely around 2030-2035, subject to jurisdiction-specific patent term adjustments or extensions.
References
- [WIPO Publication WO2010138738]
- Relevant patent databases and legal analyses (e.g., Espacenet, Patentscope)
- Industry reports on chemical and pharmaceutical patenting trends
Disclaimer: This analysis is intended for informational purposes and should not substitute for professional legal counsel or patent advice tailored to specific circumstances.
